• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

xEEGNet:迈向脑电图痴呆分类中可解释的人工智能

xEEGNet: towards explainable AI in EEG dementia classification.

作者信息

Zanola Andrea, Fabrice Tshimanga Louis, Del Pup Federico, Baiesi Marco, Atzori Manfredo

机构信息

Department of Neuroscience, University of Padua, 35128 Padua, Italy.

Padua Neuroscience Center, 35128 Padua, Italy.

出版信息

J Neural Eng. 2025 Aug 13;22(4). doi: 10.1088/1741-2552/adf6e6.

DOI:10.1088/1741-2552/adf6e6
PMID:40752516
Abstract

This work presents xEEGNet, a novel, compact, and explainable neural network for electroencephalography (EEG) data analysis. It is fully interpretable and reduces overfitting through a major parameter reduction.As an applicative use case to develop our model, we focused on the classification of common dementia conditions, Alzheimer's and frontotemporal dementia, versus controls. xEEGNet, however, is broadly applicable to other neurological conditions involving spectral alterations. We used ShallowNet, a simple and popular model in the EEGNet family, as a starting point. Its structure was analyzed and gradually modified to move from a 'black box' model to a more transparent one, without compromising performance. The learned kernels and weights were analyzed from a clinical standpoint to assess their medical significance. Model variants, including ShallowNet and the final xEEGNet, were evaluated using a robust nested-leave-n-subjects out cross-validation for unbiased performance estimates. Variability across data splits was explained using the embedded EEG representations, grouped by class and set, with pairwise separability to quantify group distinction. Overfitting was measured through training-validation loss correlation and training speed.xEEGNet uses only 168 parameters, 200 times fewer than ShallowNet, yet retains interpretability, resists overfitting, achieves comparable median performance (-1.5%), and reduces performance variability across splits. This variability is explained by the embedded EEG representations: higher accuracy correlates with greater separation between test-set controls and Alzheimer's cases, without significant influence from the training data.The capability of xEEGNet to filter specific EEG bands, learns band specific topographies and use the right EEG spectral bands for disease classification demonstrates its interpretability. While big deep learning models are typically prioritized for performance, this study shows that smaller architectures like xEEGNet can be equally effective in pathology classification, using EEG data.

摘要

这项工作提出了xEEGNet,这是一种用于脑电图(EEG)数据分析的新颖、紧凑且可解释的神经网络。它完全可解释,并通过大幅减少参数来减少过拟合。作为开发我们模型的一个应用案例,我们专注于常见痴呆症(阿尔茨海默病和额颞叶痴呆)与对照的分类。然而,xEEGNet广泛适用于其他涉及频谱改变的神经疾病。我们以EEGNet家族中一个简单且流行的模型ShallowNet为起点。分析了它的结构,并逐步进行修改,以从一个“黑箱”模型转变为一个更透明的模型,同时不影响性能。从临床角度分析了学习到的内核和权重,以评估它们的医学意义。使用稳健的嵌套留n个受试者交叉验证对包括ShallowNet和最终的xEEGNet在内的模型变体进行评估,以获得无偏的性能估计。通过按类别和数据集分组的嵌入式EEG表示来解释数据分割之间的变异性,并使用成对可分离性来量化组间差异。通过训练-验证损失相关性和训练速度来测量过拟合。xEEGNet仅使用168个参数,比ShallowNet少200倍,但仍保持可解释性,抗过拟合,实现了可比的中位数性能(-1.5%),并减少了分割间的性能变异性。这种变异性可以通过嵌入式EEG表示来解释:更高的准确率与测试集对照和阿尔茨海默病病例之间更大的分离相关,而不受训练数据的显著影响。xEEGNet过滤特定EEG频段、学习频段特定拓扑结构以及使用正确的EEG频谱频段进行疾病分类的能力证明了其可解释性。虽然大型深度学习模型通常优先考虑性能,但这项研究表明,像xEEGNet这样的较小架构在使用EEG数据进行病理分类时同样有效。

相似文献

1
xEEGNet: towards explainable AI in EEG dementia classification.xEEGNet:迈向脑电图痴呆分类中可解释的人工智能
J Neural Eng. 2025 Aug 13;22(4). doi: 10.1088/1741-2552/adf6e6.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Translational approach for dementia subtype classification using convolutional neural network based on EEG connectome dynamics.基于脑电图连接组动力学的卷积神经网络用于痴呆症亚型分类的转化方法。
Sci Rep. 2025 May 19;15(1):17331. doi: 10.1038/s41598-025-02018-7.
4
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
5
Regional cerebral blood flow single photon emission computed tomography for detection of Frontotemporal dementia in people with suspected dementia.用于检测疑似痴呆患者额颞叶痴呆的局部脑血流单光子发射计算机断层扫描
Cochrane Database Syst Rev. 2015 Jun 23;2015(6):CD010896. doi: 10.1002/14651858.CD010896.pub2.
6
A deep learning approach to direct immunofluorescence pattern recognition in autoimmune bullous diseases.深度学习方法在自身免疫性大疱性疾病中的直接免疫荧光模式识别。
Br J Dermatol. 2024 Jul 16;191(2):261-266. doi: 10.1093/bjd/ljae142.
7
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.马克 VCID 脑小血管联盟:一、入组、临床、液体方案。
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies.用于诊断路易体痴呆的多巴胺转运体成像
Cochrane Database Syst Rev. 2015 Jan 30;1(1):CD010633. doi: 10.1002/14651858.CD010633.pub2.
10
Sexual Harassment and Prevention Training性骚扰与预防培训